Tango Therapeutics Inc.

TNGX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$21.74-7.45%

2026-09-18

Financials

Valuation Metrics

Tango Therapeutics Inc.'s Market Cap is $3.14B. At end of 2025 it was $1.03B. Ranked #1637 of 3,121 in US market (top 52%), #580 of 1,463 on NASDAQ (top 40%), #98 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 37%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$3.14B	US#1,637/3,121 Sec#98/266
Revenue	$54M	US#2,767/3,121 Sec#147/266
Net Income	$-124M	US—/3,121 Sec—/266
Total Assets	$1.07B	US#2,451/3,121 Sec#101/266
Net Assets	$1.02B	US#1,755/3,121 Sec#65/266
Value
P/B	3.07x	US#1,864/3,121 Sec#97/266
P/S	58.44x	US#2,930/3,121 Sec#168/266
FCF Yield	-4.59%	US—/3,121 Sec—/266
Profitability
ROE	-12.08%	US#2,396/3,121 Sec#85/266
ROA	-11.52%	US#2,692/3,121 Sec#104/266
Op. Margin	-253.38%	US#2,784/3,121 Sec#143/266
Revenue Growth	121.47%	US#78/3,121 Sec#28/266
Financial Health
Debt Ratio	4.82%	US#37/3,121 Sec#12/266
Total Debt	$32M	US#2,688/3,121 Sec#174/266
FCF	$-144M	US#2,711/3,121 Sec#175/266
Cash	$346M	US#1,324/3,121 Sec#74/266
Current Ratio	50.82x	US#55/3,121 Sec#5/266
Performance
1Y Return	176.24%	US#64/3,121 Sec#23/266
1M Return	-13.73%	US#2,152/3,121 Sec#162/266
From 52W High	-36.78%	US#2,143/3,121 Sec#169/266
1Y MDD	-33.92%	US#1,569/3,121 Sec#102/266
Trading
Volume	5,522,419 shares	US#956/3,121 Sec#98/266
Trading Value	$123M	US#1,405/3,121 Sec#109/266
Per Share
EPS	$-0.86	US—/3,121 Sec—/266
BPS	$7.08	US#2,083/3,121 Sec#98/266